Literature DB >> 18582797

Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.

Jama Jahanyar1, Keith A Youker, Guillermo Torre-Amione, Michael M Koerner, Brian Bruckner, George P Noon, Matthias Loebe.   

Abstract

BACKGROUND: Left ventricular assist devices (LVADs) cause an influx of mast cells into the failing heart, but the underlying mechanism is unknown. This study investigates the potential role of stem cell factor (SCF) and its receptor (c-Kit) in promoting the recruitment of mast cells during heart failure and after LVAD support.
METHODS: Myocardial samples were collected from 10 end-stage heart failure patients undergoing LVAD implantation (pre-LVAD) and paired with samples taken at the time of orthotopic heart transplantation (post-LVAD). Biopsies of normal hearts served as controls. We assessed gene expression of SCF and c-Kit. In addition, we stained for SCF, c-Kit, tryptase and chymase, and utilized in situ hybridization to determine the origin of SCF.
RESULTS: SCF mRNA and overall mast cell numbers were significantly increased (p < 0.01/p < 0.001) after LVAD support as compared with paired heart failure tissues. c-Kit mRNA was significantly increased post-LVAD compared with normal tissues (p < 0.05). The c-Kit protein was expressed only in cardiac mast cells. SCF mRNA was found in endothelial cells, myocytes and interstitial cells, as confirmed by antibody staining.
CONCLUSIONS: LVADs cause an increase of SCF and c-Kit gene expression, which coincides with a surge of mast cells after ventricular unloading. This suggests that SCF functions as an important mediator for the recruitment of mast cells to the mechanically unloaded human heart.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582797     DOI: 10.1016/j.healun.2008.03.021

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

Review 1.  Ventricular assist devices: pharmacological aspects of a mechanical therapy.

Authors:  O Wever-Pinzon; J Stehlik; A G Kfoury; J V Terrovitis; N A Diakos; C Charitos; D Y Li; S G Drakos
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 2.  Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.

Authors:  Shigeru Miyagawa; Koichi Toda; Teruya Nakamura; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Daisuke Yoshioka; Tetsuya Saito; Yoshiki Sawa
Journal:  Surg Today       Date:  2015-04-04       Impact factor: 2.549

3.  Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects.

Authors:  Matina Koutroumpi; Stavros Dimopoulos; Katherini Psarra; Theodoros Kyprianou; Serafim Nanas
Journal:  World J Cardiol       Date:  2012-12-26

Review 4.  State of the art of mechanical circulatory support.

Authors:  Hari R Mallidi; Jatin Anand; William E Cohn
Journal:  Tex Heart Inst J       Date:  2014-04-01

5.  Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells.

Authors:  Elisa Yaniz-Galende; Jiqiu Chen; Elie Chemaly; Lifan Liang; Jean-Sebastien Hulot; LaTronya McCollum; Teresa Arias; Valentin Fuster; Krisztina M Zsebo; Roger J Hajjar
Journal:  Circ Res       Date:  2012-08-29       Impact factor: 17.367

6.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

Review 7.  Dynamics of progenitor cells and ventricular assist device intervention.

Authors:  Anastasia Tsiavou; Athanassios Manginas
Journal:  J Cardiovasc Transl Res       Date:  2009-10-22       Impact factor: 4.132

Review 8.  Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion.

Authors:  Kyriakos Anastasiadis; Polychronis Antonitsis; Helena Argiriadou; Georgios Koliakos; Argyrios Doumas; Andre Khayat; Christos Papakonstantinou; Stephen Westaby
Journal:  J Transl Med       Date:  2011-01-19       Impact factor: 5.531

Review 9.  Role of Inflammatory Cell Subtypes in Heart Failure.

Authors:  Derek Strassheim; Edward C Dempsey; Evgenia Gerasimovskaya; Kurt Stenmark; Vijaya Karoor
Journal:  J Immunol Res       Date:  2019-09-02       Impact factor: 4.818

10.  Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Tom A Mulder; Lucía Peña-Pérez; Anna Berglöf; Stephan Meinke; H Yesid Estupiñán; Kia Heimersson; Rula Zain; Robert Månsson; C I Edvard Smith; Marzia Palma
Journal:  Hemasphere       Date:  2021-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.